In a report released yesterday, Christopher Carey from Wells Fargo maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target of $88.00. The company’s shares closed yesterday at $86.15.
Carey covers the Consumer Defensive sector, focusing on stocks such as Coca-Cola, Colgate-Palmolive, and Clorox. According to TipRanks, Carey has an average return of 4.4% and a 52.12% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Colgate-Palmolive with a $91.21 average price target, a 5.87% upside from current levels. In a report released on February 23, Barclays also assigned a Hold rating to the stock with a $82.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $86.83 and a one-year low of $66.78. Currently, Colgate-Palmolive has an average volume of 4.94M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Colgate-Palmolive (CL) Company Description:
Colgate-Palmolive Company is a multinational consumer products name engaged in production and distribution of household, personal care, oral care, health care, and veterinary products. The company sells its products across more than 200 countries and territories. The company’s well known global brands include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Ajax, Softsoap and Hill’s pet Nutrition. It has two operating business segment – Oral, Personal and Home Care, and Pet Nutrition.
Read More on CL:
- Colgate-Palmolive Welcomes Brian Newman to Board of Directors
- Colgate-Palmolive price target raised to $97 from $88 at Argus
- Colgate-Palmolive price target raised to $96 from $85 at Bernstein
- Colgate-Palmolive price target raised to $93 from $85 at Morgan Stanley
- Colgate-Palmolive price target raised to $88 from $80 at Wells Fargo
